It would be of interest to test CVX51401 in models of retinal and choroidal leakage and neovascularization because AP-Cav was additive with an anti-VEGF antibody in reducing retinal disease and more recently shown to reduce epithelial-mesenchymal transition and laser induced subretinal fibrosis.28 Here, VEGFA is linked to Abnormal retinal morphology.